These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Diagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck Institute. García-Borreguero D; Allen RP; Kohnen R; Högl B; Trenkwalder C; Oertel W; Hening WA; Paulus W; Rye D; Walters A; Winkelmann J; Earley CJ; Sleep Med; 2007 Aug; 8(5):520-30. PubMed ID: 17544323 [TBL] [Abstract][Full Text] [Related]
31. Restless leg syndrome: is it a real problem? Cotter PE; O'Keeffe ST Ther Clin Risk Manag; 2006 Dec; 2(4):465-75. PubMed ID: 18360657 [TBL] [Abstract][Full Text] [Related]
32. Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation. Mackie S; Winkelman JW CNS Drugs; 2015 May; 29(5):351-7. PubMed ID: 26045290 [TBL] [Abstract][Full Text] [Related]
33. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation. Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465 [TBL] [Abstract][Full Text] [Related]
34. Restless Legs Syndrome in Patients With Chronic Kidney Disease. Novak M; Winkelman JW; Unruh M Semin Nephrol; 2015 Jul; 35(4):347-58. PubMed ID: 26355253 [TBL] [Abstract][Full Text] [Related]
35. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges. Zucconi M; Galbiati A; Rinaldi F; Casoni F; Ferini-Strambi L Expert Rev Neurother; 2018 Sep; 18(9):705-713. PubMed ID: 30095315 [TBL] [Abstract][Full Text] [Related]
36. Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder. Oner P; Dirik EB; Taner Y; Caykoylu A; Anlar O Tohoku J Exp Med; 2007 Nov; 213(3):269-76. PubMed ID: 17984624 [TBL] [Abstract][Full Text] [Related]
37. Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review. Xu XM; Liu Y; Jia SY; Dong MX; Cao D; Wei YD Sleep Med Rev; 2018 Apr; 38():158-167. PubMed ID: 28886918 [TBL] [Abstract][Full Text] [Related]
38. [Epidemiology of restless legs syndrome]. Ghorayeb I; Tison F Rev Neurol (Paris); 2009; 165(8-9):641-9. PubMed ID: 19345965 [TBL] [Abstract][Full Text] [Related]
39. Restless legs syndrome: clinical experience with long-term treatment. Clavadetscher SC; Gugger M; Bassetti CL Sleep Med; 2004 Sep; 5(5):495-500. PubMed ID: 15341896 [TBL] [Abstract][Full Text] [Related]
40. Is restless legs syndrome underrecognized? Current management. Vergne-Salle P; Coyral D; Dufauret K; Bonnet C; Bertin P; Trèves R Joint Bone Spine; 2006 Jul; 73(4):369-73. PubMed ID: 16213771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]